Immune Checkpoint Inhibitors and Long-term Survival of Patients With Metastatic Urothelial Cancer

This cohort study uses published clinical trial data to assess long-term survival of patients with metastatic urothelial carcinoma who are treated with immune checkpoint inhibitors.

Detalles Bibliográficos
Autores principales: Zhu, Alec, Garcia, Jorge Alberto, Faltas, Bishoy, Grivas, Petros, Barata, Pedro, Shoag, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098944/
https://www.ncbi.nlm.nih.gov/pubmed/37043205
http://dx.doi.org/10.1001/jamanetworkopen.2023.7444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098944/
https://www.ncbi.nlm.nih.gov/pubmed/37043205
http://dx.doi.org/10.1001/jamanetworkopen.2023.7444

Ejemplares similares